DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $32,539,902 | -9.5% | 2,897,587 | +0.0% | 0.56% | -1.2% |
| Q1 2024 | $35,951,187 | -11.1% | 2,896,953 | +0.1% | 0.56% | -14.5% |
| Q4 2023 | $40,450,221 | +92.2% | 2,893,435 | +103.0% | 0.66% | +74.6% |
| Q3 2023 | $21,047,250 | +58.8% | 1,425,000 | +38.9% | 0.38% | +68.8% |
| Q2 2023 | $13,257,031 | +405.4% | 1,026,086 | +310.4% | 0.22% | +40.0% |
| Q3 2016 | $2,623,000 | -28.0% | 250,000 | 0.0% | 0.16% | -28.3% |
| Q2 2016 | $3,645,000 | -24.2% | 250,000 | 0.0% | 0.22% | -17.1% |
| Q1 2016 | $4,810,000 | -20.4% | 250,000 | 0.0% | 0.27% | -10.9% |
| Q4 2015 | $6,040,000 | -12.3% | 250,000 | -10.9% | 0.30% | -24.5% |
| Q3 2015 | $6,888,000 | +51.2% | 280,700 | +44.3% | 0.40% | +61.9% |
| Q2 2015 | $4,556,000 | +59.4% | 194,500 | +52.7% | 0.25% | +14.9% |
| Q1 2015 | $2,858,000 | – | 127,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,915,000 | $38,406 | 4.80% |
| Chicago Capital, LLC | 5,845,248 | $57,341,880 | 2.85% |
| Deep Track Capital, LP | 6,350,000 | $62,293,500 | 2.56% |
| PFM Health Sciences, LP | 3,805,370 | $37,330,680 | 1.65% |
| Stonepine Capital Management, LLC | 416,519 | $4,086,051 | 1.37% |
| Rhenman & Partners Asset Management AB | 725,000 | $6,996,250 | 0.77% |
| AlphaCentric Advisors LLC | 107,500 | $1,054,575 | 0.73% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,005,000 | $19,669,050 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,943,000 | 0.44% |
| Rock Springs Capital Management LP | 1,813,758 | $17,792,966 | 0.42% |